Erik Schadde
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 46
- Liver physiology and pathology 14
- Liver Disease and Transplantation 11
- Transplantation top 5%
- Surgery top 2%
- Organ Transplantation Techniques and Outcomes 21
- Cholangiocarcinoma and Gallbladder Cancer Studies 16
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 16
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 17
-
- Cancer, Hypoxia, and Metabolism 6
Erik Schadde
66 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Hepatology 1.9k
- Transplantation 108
- Surgery 1.5k
- Oncology 683
- Epidemiology 780
Countries citing papers authored by Erik Schadde
This map shows the geographic impact of Erik Schadde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Schadde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Schadde more than expected).
Fields of papers citing papers by Erik Schadde
This network shows the impact of papers produced by Erik Schadde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Schadde. The network helps show where Erik Schadde may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erik Schadde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 5 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 27 | |
| 11 | 2019 | 2 | |
| 12 | 2019 | 16 | |
| 13 | 2018 | 8 | |
| 14 | 2017 | 27 | |
| 15 | 2016 | 1 | |
| 16 | 2016 | 7 | |
| 17 | 2015 | 157 | |
| 18 | Early Survival and Safety of ALPPSbreakdown → | 2014 | 295 |
| 19 | 2014 | 99 | |
| 20 | 2003 | 4 |
About Erik Schadde
Erik Schadde is a scholar working on Hepatology, Surgery and Oncology, having authored 69 papers that have together received 2.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (46 papers), Organ Transplantation Techniques and Outcomes (21 papers), Liver Disease Diagnosis and Treatment (17 papers), Pancreatic and Hepatic Oncology Research (16 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers), Liver physiology and pathology (14 papers), Liver Disease and Transplantation (11 papers) and Cancer, Hypoxia, and Metabolism (6 papers). The work is most often cited by research in Hepatology (1.9k citations), Transplantation (108 citations) and Surgery (1.5k citations). Erik Schadde has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Pierre–Alain Clavien, Eduardo de Santibáñes, Andreas A. Schnitzbauer, Roberto Hernandez‐Alejandro, Victoria Ardiles, Christoph Tschuor, Ksenija Slankamenac, Marcel Autran C. Machado, Dimitri Aristotle Raptis and Massimo Malagò. Their work appears in journals such as HPB, Surgery, Journal of Clinical Oncology, Journal of Gastrointestinal Surgery and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.